Pfizer 3Q Revenues: $14.0 billion (-16%)  3Q Earnings:  $3.2 billion (-14%) YTD Revenues: $43.9 billion (-11%) YTD Earnings: $8.3 billion (-4%) Comments: Biopharma revenues were $12.1 billion in the quarter, down 18%. Primary care revenues were down 39% to $3.6 billion. Specialty care revenues were $3.4 billion down 10%. Established products sales were up 7% to $2.4 billion. U.S. revenues were $5.6 billion, down 18% and International revenues were $8.3 billion, down 14%, primarily due to th...